Boehringer Ingelheim Pharmaceuticals Inc. et al v. Laurus Labs Ltd. et al
| Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation |
| Laurus Labs Ltd. and Laurus Generics Inc. |
| 1:2022cv00220 |
| February 18, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 13, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Laurus Labs Ltd. for Laurus Generics Inc. filed by Laurus Generics Inc., Laurus Labs Ltd.. (Poff, Adam) |
| Filing 12 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Laurus Labs Ltd., Laurus Generics Inc..(Poff, Adam) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd)
|
|
ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
|
|
Filing 10
ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
|
| Filing 9 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Laurus Labs Ltd. served on 3/18/2022, answer due 4/8/2022. (Dellinger, Megan) |
| Filing 8 SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Laurus Generics Inc. served on 3/18/2022, answer due 4/8/2022. (Dellinger, Megan) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 7 Summons Issued with Magistrate Consent Notice attached as to Laurus Labs Ltd. on 2/18/2022. (twk) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to Laurus Generics Inc. on 2/18/2022. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 3, 2022. Date of Expiration of Patent: April 3, 2034. Thirty Month Stay Deadline: Not Applicable. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Laurus Generics Inc., Laurus Labs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3807116.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
